1α,25-dihydroxyvitamin D3 stimulates activin A production to fine-tune osteoblast-induced mineralization

Journal of Cellular Physiology

Volumn 228, Issue 11, 2013, Pages 2167-2174

  Woeckel, V J ^a   Van der Eerden, B C J ^a   Schreuders Koedam, M ^a   Eijken, M ^a   Van Leeuwen, J P T M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; CALCITRIOL; FOLLISTATIN; OSTEOCALCIN; WARFARIN;

ARTICLE; BGLAP GENE; BONE MINERALIZATION; CLEC3B GENE; CONTROLLED STUDY; DOWN REGULATION; GADPH GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; INHBA GENE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN INTERACTION; SMAD7 GENE;

ACTIVINS; CALCIFICATION, PHYSIOLOGIC; CELL LINE; FOLLISTATIN; GENE EXPRESSION REGULATION; HUMANS; LECTINS, C-TYPE; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOCALCIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; VITAMIN D; WARFARIN;

EID: 84881231055     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24388     Document Type: Article

References (53)

1. Alliston T, Choy L, Ducy P, Karsenty G, Derynck R. 2001. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20:2254-2272.
2. Artaza JN, Norris KC. 2009. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 200:207-221.
3. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino AC. 2003. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18:1088-1098.
4. Barna BP, Malur A, Dalrymple H, Karnekar R, Culver DA, Abraham S, Singh RJ, Brescia D, Kavuru MS, Thomassen MJ. 2009. A novel 1, 25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP). Autoimmunity 42:56-62.
5. Boivin G, Meunier PJ. 2002. Changes in bone remodeling rate influence the degree of mineralization of bone. Connect Tissue Res 43:535-537.
6. Boskey AL, Wians FH, Jr., Hauschka PV. 1985. The effect of osteocalcin on in vitro lipid-induced hydroxyapatite formation and seeded hydroxyapatite growth. Calcif Tissue Int 37:57-62.
7. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. 1998. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23:187-196.
8. Bruedigam C, Koedam M, Chiba H, Eijken M, van Leeuwen JP. 2008. Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: Fine-tuning by hormonal regulation and mRNA stability. FEBS Lett 582:1618-1624.
9. Bruedigam C, Driel M, Koedam M, Peppel J, van der Eerden BC, Eijken M, van Leeuwen JP. 2011. Basic techniques in human mesenchymal stem cell cultures: Differentiation into osteogenic and adipogenic lineages, genetic perturbations, and phenotypic analyses. Curr Protoc Stem Cell Biol Chapter 1: Unit1H3.
10. Chantry AD, Heath D, Mulivor AW, Pearsall S, Baud'huin M, Coulton L, Evans H, Abdul N, Werner ED, Bouxsein ML, Key ML, Seehra J, Arnett TR, Vanderkerken K, Croucher P. 2010. Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo. J Bone Miner Res 25:2633-2646.
11. Chiba H, Sawada N, Ono T, Ishii S, Mori M. 1993. Establishment and characterization of a simian virus 40-immortalized osteoblastic cell line from normal human bone. Jpn J Cancer Res 84:290-297.
12. Coutu DL, Wu JH, Monette A, Rivard GE, Blostein MD, Galipeau J. 2008. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 283:17991-18001.
13. DeLuca HF. 1988. The vitamin D story: A collaborative effort of basic science and clinical medicine. FASEB J 2:224-236.
14. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. 1998. Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17:3091-3100.
15. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584.
16. Dowd P, Hershline R, Ham SW, Naganathan S. 1995. Vitamin K and energy transduction: A base strength amplification mechanism. Science 269:1684-1691.
17. Drabek K, van de Peppel J, Eijken M, van Leeuwen JP. 2011. GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release. J Bone Miner Res 26:2045-2051.
18. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G. 1996. Increased bone formation in osteocalcin-deficient mice. Nature 382:448-452.
19. Eijken M, Koedam M, van Driel M, Buurman CJ, Pols HA, van Leeuwen JP. 2006. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol 248:87-93.
20. Eijken M, Swagemakers S, Koedam M, Steenbergen C, Derkx P, Uitterlinden AG, van der Spek PJ, Visser JA, de Jong FH, Pols HA, van Leeuwen JP. 2007. The activin A-follistatin system: Potent regulator of human extracellular matrix mineralization. FASEB J 21:2949-2960.
21. Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J, Mundy GR. 1994. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9:855-863.
22. Harrison CA, Gray PC, Vale WW, Robertson DM. 2005. Antagonists of activin signaling: Mechanisms and potential biological applications. Trends Endocrinol Metab 16:73-78.
23. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. 1996. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317:59-64.
24. Ingram RT, Bonde SK, Riggs BL, Fitzpatrick LA. 1994. Effects of transforming growth factor beta (TGF beta) and 1, 25 dihydroxyvitamin D3 on the function, cytochemistry and morphology of normal human osteoblast-like cells. Differentiation 55:153-163.
25. Ishisaki A, Yamato K, Nakao A, Nonaka K, Ohguchi M, ten Dijke P, Nishihara T. 1998. Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells. J Biol Chem 273:24293-24296.
26. Itoh S, Itoh F, Goumans MJ, Ten Dijke P. 2000. Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem 267:6954-6967.
27. Janssens K, ten Dijke P, Janssens S, Van Hul W. 2005. Transforming growth factor-beta1 to the bone. Endocr Rev 26:743-774.
28. Jeong HM, Cho DH, Jin YH, Chung JO, Chung MY, Chung DJ, Lee KY. 2011. Inhibition of osteoblastic differentiation by warfarin and 18-alpha-glycyrrhetinic acid. Arch Pharm Res 34:1381-1387.
29. Karunaratne A, Esapa C, Hiller J, Boyde A, Head R, Bassett J, Terrill N, Williams G, Brown M, Croucher P, Brown S, Cox R, Barber A, Thakker R, Gupta H. 2012. Significant deterioration in nanomechanical quality occurs through incomplete extrafibrillar mineralization in rachitic bone: Evidence from in-situ synchrotron X-ray scattering and backscattered electron imaging. J Bone Miner Res 4:876-890.
30. Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S. 1998. Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338:653-661.
31. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G. 1989. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci USA 86:1143-1147.
32. Liu P, Oyajobi BO, Russell RG, Scutt A. 1999. Regulation of osteogenic differentiation of human bone marrow stromal cells: Interaction between transforming growth factor-beta and 1, 25(OH)(2) vitamin D(3) In vitro. Calcif Tissue Int 65:173-180.
33. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81.
34. Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K. 2004. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 23:552-563.
35. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. 1999. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 21:142-144.
36. Nagasaki T, Hino M, Inaba M, Nishizawa Y, Morii H, Otani S. 1997. Inhibition by 1alpha, 25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells. Arch Biochem Biophys 343:181-187.
37. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT. 1990. Identification of a DNA sequence responsible for binding of the 1, 25-dihydroxyvitamin D3 receptor and 1, 25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci USA 87:9995-9999.
38. Okabe-Kado J, Honma Y, Hozumi M. 1991. Inhibition by vitamin D3 of erythroid differentiation of human leukemia line cells induced by transforming growth factor beta or erythroid differentiation factor (activin A). Leuk Res 15:721-726.
39. Prince CW, Butler WT. 1987. 1, 25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res 7:305-313.
40. Romberg RW, Werness PG, Riggs BL, Mann KG. 1986. Inhibition of hydroxyapatite crystal growth by bone-specific and other calcium-binding proteins. Biochemistry 25:1176-1180.
41. Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhager JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB. 1996. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: Reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Endocrinology 137:2001-2011.
42. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM. 2002. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161:2035-2046.
43. Subramaniam N, Leong GM, Cock TA, Flanagan JL, Fong C, Eisman JA, Kouzmenko AP. 2001. Cross-talk between 1, 25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements. J Biol Chem 276:15741-15746.
44. van Driel M, Koedam M, Buurman CJ, Roelse M, Weyts F, Chiba H, Uitterlinden AG, Pols HA, van Leeuwen JP. 2006. Evidence that both 1alpha, 25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J Cell Biochem 99:922-935.
45. Wain HM, Bruford EA, Lovering RC, Lush MJ, Wright MW, Povey S. 2002. Guidelines for human gene nomenclature. Genomics 79:464-470.
46. Wallin R, Hutson SM. 2004. Warfarin and the vitamin K-dependent gamma-carboxylation system. Trends Mol Med 10:299-302.
47. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, Bourdeau V, Konstorum A, Lallemant B, Zhang R, Mader S, White JH. 2005. Large-scale in silico and microarray-based identification of direct 1, 25-dihydroxyvitamin D3 target genes. Mol Endocrinol 19:2685-2695.
48. Woeckel VJ, Alves RD, Swagemakers SM, Eijken M, Chiba H, van der Eerden BC, van Leeuwen JP. 2010. 1Alpha, 25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles. J Cell Physiol 225:593-600.
49. Woeckel VJ, Eijken M, van de Peppel J, Chiba H, van der Eerden BC, van Leeuwen JP. 2012. IFNbeta impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation. J Cell Physiol 6:2668-2676.
50. Yanagi Y, Suzawa M, Kawabata M, Miyazono K, Yanagisawa J, Kato S. 1999. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J Biol Chem 274:12971-12974.
51. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S. 1999. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:1317-1321.
52. Zebger-Gong H, Muller D, Diercke M, Haffner D, Hocher B, Verberckmoes S, Schmidt S, D'Haese PC, Querfeld U. 2011. 1, 25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: Up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens 29:339-348.
53. Zur Nieden NI, Price FD, Davis LA, Everitt RE, Rancourt DE. 2007. Gene profiling on mixed embryonic stem cell populations reveals a biphasic role for beta-catenin in osteogenic differentiation. Mol Endocrinol 21:674-685.